Valuation: Global Hemp Group Inc.

Market Cap 607K 434K 389K 359K 325K 41.36M 617K 4.28M 1.71M 21.64M 1.63M 1.6M 68.55M P/E 2022
-2.15x
P/E 2023 -0.44x
Enterprise Value 4.16M 2.97M 2.66M 2.46M 2.22M 283M 4.23M 29.33M 11.7M 148M 11.16M 10.93M 470M EV / Sales 2022
-
EV / Sales 2023 -
Free-Float
93.99%
Yield 2022 *
-
Yield 2023 -
3 years 0
Extreme 0.005
0.12
5 years 0
Extreme 0.005
0.9
10 years 0
Extreme 0.005
7.8
Manager TitleAgeSince
Chief Executive Officer - -
Director of Finance/CFO 47 2024-08-22
Chief Tech/Sci/R&D Officer 66 -
Director TitleAgeSince
Chairman - 2020-05-20
Director/Board Member - 2023-02-13
Director/Board Member - 2023-10-02
Date Insider Type Main position Quantity % Market Cap. Importance
1/14/25 Other

Chief Financial Officer

0 0%
1/14/25 Other

Chief Financial Officer

0 0%
1/14/25 Other

Chief Financial Officer

0 0%
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--%-.--%-20.00% 499K
+0.42%-4.39%+12.07%+36.26% 116B
+3.21%+2.30%+2.07%+112.21% 104B
+2.73%+8.63%+126.13%+1,039.57% 62.85B
+2.20%+11.59%+48.37%+85.04% 29.89B
+1.01%+3.74%-7.04%+92.23% 29.55B
+2.97%+3.96%+44.71%+98.09% 27.83B
+0.77%-0.02%+29.37%+409.36% 21.79B
-0.72%+5.53%-18.98%-7.55% 20.66B
0.00%-0.63%-4.27%+31.71% 17.09B
Average +1.26%+2.78%+23.24%+187.69% 42.87B
Weighted average by Cap. +1.71%+2.03%+28.44%+229.63%

Financials

2022 2023
Net sales - -
Net income -2.17M -1.55M -1.39M -1.28M -1.16M -147M -2.2M -15.27M -6.09M -77.19M -5.81M -5.69M -244M -2.58M -1.85M -1.65M -1.52M -1.38M -176M -2.62M -18.19M -7.26M -91.97M -6.93M -6.78M -291M
Net Debt 2.89M 2.07M 1.85M 1.71M 1.55M 197M 2.94M 20.38M 8.13M 103M 7.76M 7.59M 326M 3.55M 2.54M 2.28M 2.1M 1.9M 242M 3.61M 25.04M 9.99M 127M 9.53M 9.33M 401M
Logo Global Hemp Group Inc.
Global Hemp Group Inc. is a Canada-based company. The Company is focused on two business segments: Industrial Hemp and Health & Wellness (Biopharma). The Industrial Hemp segment primary focus lies in the environmental uses of hemp for construction and hemp for sustainable bio-energy sources, both contributing to a carbon-negative footprint. It is also focused on aligning with its hemp agro-industrial zone (HAIZ) strategy to achieve a carbon-negative footprint. Its principal feature of the HAIZ concept is the proximity of the industrial plant to the supply of raw materials and final markets. The Health and Wellness segment is focused on the acquisition of exclusive licensing of patents and intellectual property (IP). It acquired exclusive rights to key patents and IP of Apollon Formularies plc., a UK-based international pharmaceutical company whose formulations and patents specialize in developing cancer treatments from natural biologics, including cannabinoids and functional mushrooms.
Employees
-